Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

German vaccine authority recommends AstraZeneca vaccine for older people - FAZ newspaper

Thu, 04th Mar 2021 10:30

BERLIN, March 4 (Reuters) - Germany's vaccine authority will
recommend AstraZeneca's coronavirus vaccine for
over-65s, the Frankfurter Allgemeine reported, news that
promises an easing of the supply constraints that have slowed
the country's vaccine roll-out.

The newspaper reported on Thursday that the Permanent
Vaccine Commission's (STIKO) recommendation had already been
written, but was still being discussed internally before being
made public.

STIKO could not immediately be reached for comment.
(Reporting by Thomas Escritt
Editing by Riham Alkousa)

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.